Craft
Abiomed

Abiomed

Products

8

FY, 2019

Revenue

$1 B

FY, 2022

Market Capitalization

$17.3 B

2022-12-23

Abiomed Summary

Company summary

Overview
Abiomed is a company providing medical devices for circulatory support. It offers Impella, a small heart pump designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Abiomed also provides clinical and product information, from professional resources to video training.
Type
Public
Status
Active
Founded
1981
HQ
Danvers, MA, US | view all locations
Website
http://abiomed.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Michael R Minogue

    Michael R Minogue, Chairman, President, Chief Executive Officer

  • Marc A Began

    Marc A Began, Vice President, General Counsel

  • William J Bolt

    William J Bolt, Senior Vice President-Global Product Operations

  • Andrew J Greenfield

    Andrew J Greenfield, Vice President, Chief Commercial Officer

Operating MetricsView all

Trademarks

8
33.3%

FY, 2019

Facilities Owned

2

FY, 2019

Facilities Leased

3

FY, 2019

LocationsView all

4 locations detected

  • Danvers, MA HQ

    United States

    22 Cherry Hill Dr

  • Halethorpe, MD

    United States

    1500 Joh Ave #190

  • Aachen, NRW

    Germany

    Neuenhofer Weg 3

  • Tokyo, Tokyo

    Japan

    2-chōme-2-1 Nihonbashimuromachi

Abiomed Financials

Summary financials

Revenue (Q2, 2023)
$265.9M
Gross profit (Q2, 2023)
$217.0M
Net income (Q2, 2023)
$106.1M
EBIT (Q2, 2023)
$58.0M

Footer menu